← Back to Screener
Bio-Techne Corp. (TECH)
Price$60.58
Favorite Metrics
Price vs S&P 500 (26W)-5.33%
Price vs S&P 500 (4W)8.36%
Market Capitalization$9.38B
P/E Ratio (Annual)127.84x
Indicated Dividend Yield (Annual)0.53%
All Metrics
P/CF (Annual)32.63x
Book Value / Share (Quarterly)$12.90
P/TBV (Annual)5.19x
Indicated Dividend (Annual)$0.32
Revenue Growth (3Y)3.33%
Cash Flow / Share (Quarterly)$1.43
Payout Ratio (TTM)37.96%
Price vs S&P 500 (YTD)-0.92%
Gross Margin (TTM)66.60%
Net Profit Margin (TTM)6.58%
EPS (TTM)$0.51
10-Day Avg Trading Volume1.98M
EPS Excl Extra (TTM)$0.51
Revenue Growth (5Y)10.55%
EPS (Annual)$0.46
Dividend / Share (Annual)$0.32
ROI (Annual)3.24%
Gross Margin (Annual)66.50%
Net Profit Margin (5Y Avg)17.06%
Cash / Share (Quarterly)$1.11
P/E Basic Excl Extra (TTM)117.30x
Revenue Growth QoQ (YoY)-0.39%
EPS Growth (5Y)-20.58%
P/E Normalized (Annual)127.84x
ROA (Last FY)2.87%
Revenue Growth TTM (YoY)1.64%
EBITD / Share (TTM)$1.41
ROE (5Y Avg)10.29%
Operating Margin (TTM)9.62%
Cash Flow / Share (Annual)$1.66
P/B Ratio4.67x
P/B Ratio (Quarterly)4.56x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)7.79x
Net Interest Coverage (TTM)45.00x
ROA (TTM)3.12%
EPS Growth QoQ (YoY)11.46%
EV / EBITDA (TTM)42.72x
EPS Incl Extra (Annual)$0.46
Current Ratio (Annual)3.46x
Quick Ratio (Quarterly)3.08x
3-Month Avg Trading Volume2.22M
52-Week Price Return25.95%
EV / Free Cash Flow (Annual)36.91x
P/E Incl Extra (TTM)117.30x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$10.75
P/S Ratio (Annual)7.69x
Asset Turnover (Annual)0.48x
52-Week High$72.16
Operating Margin (5Y Avg)21.83%
EPS Excl Extra (Annual)$0.46
CapEx CAGR (5Y)-9.72%
Tangible BV CAGR (5Y)12.43%
26-Week Price Return1.56%
Quick Ratio (Annual)2.38x
13-Week Price Return-13.41%
Total Debt / Equity (Annual)0.18x
Current Ratio (Quarterly)4.54x
Enterprise Value$9,470.407
Revenue / Share Growth (5Y)10.25%
Asset Turnover (TTM)0.47x
Book Value / Share Growth (5Y)6.63%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.21x
Pretax Margin (Annual)8.07%
Cash / Share (Annual)$1.05
3-Month Return Std Dev39.81%
Gross Margin (5Y Avg)67.46%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-6.25%
EBITDA Interim CAGR (5Y)-1.05%
ROE (Last FY)3.83%
Net Interest Coverage (Annual)24.13x
EPS Basic Excl Extra (Annual)$0.46
P/FCF (TTM)42.07x
Receivables Turnover (TTM)6.04x
EV / Free Cash Flow (TTM)42.46x
Total Debt / Equity (Quarterly)0.13x
EPS Incl Extra (TTM)$0.51
Receivables Turnover (Annual)5.44x
ROI (TTM)3.50%
Dividend Growth Rate (5Y)0.11%
P/S Ratio (TTM)7.72x
Pretax Margin (5Y Avg)19.41%
Revenue / Share (Annual)$7.64
Tangible BV / Share (Annual)$10.02
Forward P/E30.57x
Free OCF CAGR (5Y)10.82%
Price vs S&P 500 (52W)-8.69%
P/E Ratio (TTM)117.30x
EPS Growth TTM (YoY)-48.40%
Year-to-Date Return3.01%
5-Day Price Return3.27%
EPS Normalized (Annual)$0.46
ROA (5Y Avg)7.59%
Net Profit Margin (Annual)6.02%
Month-to-Date Return15.92%
Cash Flow / Share (TTM)$2.20
EBITD / Share (Annual)$0.83
EPS Growth (3Y)-34.80%
Operating Margin (Annual)8.38%
LT Debt / Equity (Annual)0.18x
P/CF (TTM)37.64x
ROI (5Y Avg)8.77%
P/E Excl Extra (TTM)117.30x
LT Debt / Equity (Quarterly)0.13x
EPS Basic Excl Extra (TTM)$0.51
P/TBV (Quarterly)5.47x
Payout Ratio (Annual)68.65%
P/B Ratio (Annual)4.20x
Dividend / Share (TTM)$0.32
Inventory Turnover (TTM)2.06x
Pretax Margin (TTM)9.30%
Book Value / Share (Annual)$12.38
Price vs S&P 500 (13W)-15.79%
Net Margin Growth (5Y)-27.97%
Dividend Yield (TTM)0.53%
Beta1.51x
P/FCF (Annual)36.57x
Revenue / Share (TTM)$7.74
ROE (TTM)4.04%
52-Week Low$46.01
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.09
4.09
4.04
4.04
Industry Peers — Biological Products(88)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 11.09x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
HALOHalozyme Therapeutics, Inc. | 5.90x | 37.55% | 83.62% | 22.89% | $69.57 |
About
Bio-Techne is a life sciences manufacturer providing consumables and instruments to pharmaceutical, biotech, academic, and diagnostic markets through two segments: protein sciences (75% of revenue), supplying reagents and analytical instruments including antibodies for protein analysis, and diagnostics and genomics (25%), offering diagnostic reagents, molecular diagnostics, and spatial biology products. The company generates approximately 55% of revenue from the United States, with the remainder from Europe, Asia-Pacific, and other international markets. This diversified product portfolio and geographic footprint position the company to serve multiple end-markets within the life sciences research and diagnostic sectors.